date,title,source
Nov-01-18,Bio-Path Holdings to Present Clinical Data at the 60th Annual American Society of Hematology Annual Meeting,GlobeNewswire
Nov-08-18,"Bio-Path Holdings to Announce Third Quarter 2018 Financial Results on November 15, 2018",GlobeNewswire
Nov-15-18,Bio-Path: 3Q Earnings Snapshot,Associated Press
Nov-15-18,Bio-Path Holdings Reports Third Quarter 2018 Financial Results,GlobeNewswire
Dec-03-18,Bio-Path Holdings Presents Interim Data from Phase 2 Study Evaluating Prexigebersen as a Treatment for Acute Myeloid Leukemia at the 60th Annual American Society of Hematology Annual Meeting,GlobeNewswire
Dec-26-18,"Could Bio-Path Holdings, Inc.s (NASDAQ:BPTH) Investor Composition Influence The Stock Price?",Simply Wall St.
Dec-27-18,Bio-Path Holdings Provides Clinical Update and 2019 Business Outlook,GlobeNewswire
Jan-14-19,"Bio-Path Holdings, Inc. Announces Pricing of Public Offering of Common Stock",GlobeNewswire
Jan-14-19,"Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock",GlobeNewswire
Jan-16-19,"The Daily Biotech Pulse: Revance Common Stock Offering, Adcom Catalyst For Amgen",Benzinga
Jan-17-19,"Bio-Path Holdings, Inc. Announces Closing of Public Offering of Common Stock",GlobeNewswire
Jan-18-19,"Bio-Path Holdings, Inc. Announces $1.7 Million Registered Direct Offering Priced At-the-Market",GlobeNewswire
Jan-18-19,Bio-Path Holdings Announces 1-for-20 Reverse Stock Split,GlobeNewswire
Jan-23-19,"Bio-Path Holdings, Inc. Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market",GlobeNewswire
Jan-24-19,"Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH)",ACCESSWIRE
